These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 21130673)

  • 21. Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
    Javitt GH; Stanley E; Hudson K
    Oklahoma Law Rev; 2004; 57(2):251-302. PubMed ID: 15658034
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA approves genetic test for women with breast cancer.
    Josefson D
    BMJ; 1998 Jan; 316(7126):168. PubMed ID: 9468672
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA halts sale of genetic test sold to consumers.
    McCarthy M
    BMJ; 2013 Nov; 347():f7126. PubMed ID: 24284347
    [No Abstract]   [Full Text] [Related]  

  • 24. Consumer alert: ethical issues raised by the sale of genetic tests directly to consumers.
    Wasson K
    Am J Bioeth; 2008 Jun; 8(6):16-8. PubMed ID: 18726774
    [No Abstract]   [Full Text] [Related]  

  • 25. Establishing clinical utility of pharmacogenetic tests in the post-FDAAA era.
    Evans BJ
    Clin Pharmacol Ther; 2010 Dec; 88(6):749-51. PubMed ID: 21081943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic testing and the clinical laboratory improvement amendments of 1988: present and future.
    Schwartz MK
    Clin Chem; 1999 May; 45(5):739-45. PubMed ID: 10222376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Environmental biotechnology in the postgenomics era.
    Chakrabarty AM
    Biotechnol Adv; 2003 Dec; 22(1-2):3-8. PubMed ID: 14623038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FDA Oversight of Laboratory-Developed Tests: Where Are We Now?
    Gatter K
    Arch Pathol Lab Med; 2017 Jun; 141(6):746-748. PubMed ID: 28557601
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA pushes for control over laboratory-developed tests.
    Ratner M
    Nat Biotechnol; 2014 Sep; 32(9):855. PubMed ID: 25203023
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA regulation of genetic testing: institutional reluctance and public guardianship.
    Huang A
    Food Drug Law J; 1998; 53(3):555-91. PubMed ID: 10346728
    [No Abstract]   [Full Text] [Related]  

  • 31. FDA moves to regulate thousands of diagnostic tests.
    Caffrey MK
    Am J Manag Care; 2014 Aug; 20(11 Spec No.):E12. PubMed ID: 25618155
    [No Abstract]   [Full Text] [Related]  

  • 32. Looming regulations and FDA oversight mean an uncertain reimbursement climate in 2016.
    Wolf R
    MLO Med Lab Obs; 2016 May; 48(5):26-7. PubMed ID: 27323455
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA oversight of laboratory-developed tests: is it necessary, and how would it impact clinical laboratories?
    Scott MG; Ashwood ER; Annesley TM; Leonard DG; Burgess MC
    Clin Chem; 2013 Jul; 59(7):1017-22. PubMed ID: 23536512
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA proposes tighter regulation over genetic lab tests: federal agency cites need to improve test quality, minimize risk to patients.
    Levenson D
    Am J Med Genet A; 2015 Feb; 167A(2):viii-ix. PubMed ID: 25604663
    [No Abstract]   [Full Text] [Related]  

  • 35. Newborn screening: current status.
    Arn PH
    Health Aff (Millwood); 2007; 26(2):559-66. PubMed ID: 17339686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine.
    Evans JP; Watson MS
    JAMA; 2015 Feb; 313(7):669-70. PubMed ID: 25560537
    [No Abstract]   [Full Text] [Related]  

  • 37. The FDA and genomic tests--getting regulation right.
    Evans BJ; Burke W; Jarvik GP
    N Engl J Med; 2015 Jun; 372(23):2258-64. PubMed ID: 26014592
    [No Abstract]   [Full Text] [Related]  

  • 38. The future of direct-to-consumer clinical genetic tests.
    Frueh FW; Greely HT; Green RC; Hogarth S; Siegel S
    Nat Rev Genet; 2011 Jun; 12(7):511-5. PubMed ID: 21629275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulating laboratory-developed tests: devil will be in details.
    McNeil C
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838442
    [No Abstract]   [Full Text] [Related]  

  • 40. The regulation of home diagnostic tests for genetic disorders: can the FDA deny a premarket application on the basis of the device's social impacts?
    Kerouac JD
    J Biolaw Bus; 2002; 5(1):34-43. PubMed ID: 12751500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.